Literature DB >> 29361396

Childhood-onset form of myotonic dystrophy type 1 and autism spectrum disorder: Is there comorbidity?

N Angeard1, E Huerta2, A Jacquette3, D Cohen4, J Xavier4, M Gargiulo5, L Servais6, B Eymard6, D Héron3.   

Abstract

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with neuromuscular symptoms and brain dysfunctions. Depending on the phenotypic expression, the degree of cognitive impairment remains heterogeneous, ranging from moderate to severe intellectual disability in the congenital form, to executive, visuospatial and personality dysfunction in the adult-onset form. Studies exploring the cognitive or psychiatric impairments in the childhood form of DM1, characterized by an age of onset between one and ten years, uneventful pre and post natal history and normal development the first year of life, are scarce and show conflicting results in regard to a comorbid diagnosis of Autism Spectrum Disorder (ASD). The aim of the current review is to summarize diagnostic criteria and update the state of the debate regarding comorbidity. Evidence from 9 studies collected in PubMed database (representing a total of 175 cases) focusing on clinical, neuropsychological and neuroimaging domains in childhood DM1 is considered and similarities or differences between childhood DM1 and ASD are identified. Highlighting what is known about the neurocognitive features specific to the childhood-onset form of DM1 could help (1) propose early screening regarding socio-emotional and attentional/executive functions or (2) implement therapeutic programs based on reinforcement of executive skills or social cognition.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorder; Childhood-onset form; Comorbidity; Myotonic dystrophy type 1; Neuropsychological profiles; Social communication disorder

Mesh:

Year:  2017        PMID: 29361396     DOI: 10.1016/j.nmd.2017.12.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Deprivation of Muscleblind-Like Proteins Causes Deficits in Cortical Neuron Distribution and Morphological Changes in Dendritic Spines and Postsynaptic Densities.

Authors:  Kuang-Yung Lee; Ho-Ching Chang; Carol Seah; Li-Jen Lee
Journal:  Front Neuroanat       Date:  2019-07-30       Impact factor: 3.856

Review 2.  A Promising Future for Stem-Cell-Based Therapies in Muscular Dystrophies-In Vitro and In Vivo Treatments to Boost Cellular Engraftment.

Authors:  Daniela Gois Beghini; Samuel Iwao Horita; Liana Monteiro da Fonseca Cardoso; Luiz Anastacio Alves; Kanneboyina Nagaraju; Andrea Henriques-Pons
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

3.  Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?

Authors:  Garazi Labayru; Irati Arenzana; Jone Aliri; Miren Zulaica; Adolfo López de Munain; Andone Sistiaga A
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.